| Müügiloata ravim |
1713798
|
54767414MMY4001 |
L01XC24 |
daratumumab |
infusioonilahuse kontsentraat |
20mg 1ml 20ml 4TK |
Vetter Pharma-Fertigung GmbH & Co. KG |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1069400
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 10ml 1TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
30.12.2011 |
 |
|
Jah |
Jah |
| Müügiloaga pakend |
1069422
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 100ml 1TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
02.11.2021 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1069411
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 20ml 1TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
15.02.2012 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1136540
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 5ml 5TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
26.04.2007 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1150018
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 10ml 5TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
09.07.2010 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1021778
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 5ml 1TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
21.01.2011 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1069433
|
5-FLUOROURACIL "EBEWE" |
L01BC02 |
fluorouratsiil |
süste-/infusioonilahus |
50mg 1ml 20ml 5TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
26.04.2007 |
|
|
Jah |
Jah |
| Müügiloaga pakend |
1860140
|
ABECMA |
L01XX87 |
idekabtageenvikleutseel |
infusioonidispersioon |
1TK |
Celgene Europe B.V. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1846885
|
ABEVMY |
L01XC07 |
bevatsizumab |
infusioonilahuse kontsentraat |
25mg 1ml 16ml 3TK |
Mylan IRE Healthcare Limited |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1846852
|
ABEVMY |
L01XC07 |
bevatsizumab |
infusioonilahuse kontsentraat |
25mg 1ml 4ml 5TK |
Mylan IRE Healthcare Limited |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1846841
|
ABEVMY |
L01XC07 |
bevatsizumab |
infusioonilahuse kontsentraat |
25mg 1ml 4ml 1TK |
Mylan IRE Healthcare Limited |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1846863
|
ABEVMY |
L01XC07 |
bevatsizumab |
infusioonilahuse kontsentraat |
25mg 1ml 16ml 1TK |
Mylan IRE Healthcare Limited |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1846874
|
ABEVMY |
L01XC07 |
bevatsizumab |
infusioonilahuse kontsentraat |
25mg 1ml 16ml 2TK |
Mylan IRE Healthcare Limited |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1847415
|
ABIRATERONE ACCORD |
L02BX03 |
abirateroon |
tablett |
500mg 56TK |
Accord Healthcare S.L.U. |
R |
|
|
üksikannuseline blister |
|
|
|
|
Jah |
| Müügiloaga pakend |
1847325
|
ABIRATERONE ACCORD |
L02BX03 |
abirateroon |
tablett |
250mg 120TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1847426
|
ABIRATERONE ACCORD |
L02BX03 |
abirateroon |
tablett |
500mg 60TK |
Accord Healthcare S.L.U. |
R |
|
|
üksikannuseline blister |
|
|
|
|
Jah |
| Müügiloata ravim |
1553442
|
ABIRATERONE ACETATE |
L02BX03 |
abirateroon |
tablett |
250mg 120TK |
Janssen-Cilag International N.V. |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1801055
|
ABIRATERONE G.L. PHARMA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 60TK |
G.L. Pharma GmbH |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1801044
|
ABIRATERONE G.L. PHARMA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 56TK |
G.L. Pharma GmbH |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1856123
|
ABIRATERONE KRKA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 56TK |
KRKA, d.d., Novo mesto |
R |
|
|
taskublister |
|
|
|
|
Jah |
| Müügiloaga pakend |
1856101
|
ABIRATERONE KRKA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 56TK |
KRKA, d.d., Novo mesto |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1856112
|
ABIRATERONE KRKA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 60TK |
KRKA, d.d., Novo mesto |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1801022
|
ABIRATERONE NORAMEDA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 60TK |
UAB Norameda |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1801011
|
ABIRATERONE NORAMEDA |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 56TK |
UAB Norameda |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1801673
|
ABIRATERONE RICHTER |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 60TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1814723
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 60TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1806926
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 84TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1814712
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 30TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1814701
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 28TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1806915
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 60TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1806937
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 112TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1845187
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 56TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1806904
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
500mg 56TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1814734
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 84TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1845198
|
ABIRATERONE SANDOZ |
L02BX03 |
abirateroon |
õhukese polümeerikattega tablett |
1000mg 90TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloata ravim |
1840553
|
ABL001 |
L01EA06 |
astsiminiib |
õhukese polümeerikattega tablett |
40mg 30TK |
Novartis Pharma AG |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1342998
|
ABRAXANE |
L01CD01 |
paklitakseel |
infusioonidispersiooni pulber |
100mg 1TK |
Bristol-Myers Squibb Pharma EEIG |
R |
|
|
|
03.11.2021 |
|
|
|
Jah |
| Müügiloaga pakend |
1636309
|
ABRAXANE |
L01CD01 |
paklitakseel |
infusioonidispersiooni pulber |
250mg 1TK |
Bristol-Myers Squibb Pharma EEIG |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1706363
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
300mcg 0.5ml 0.5ml 3TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1706374
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
300mcg 0.5ml 0.5ml 10TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1664872
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
480mcg 0.5ml 0.5ml 5TK |
Accord Healthcare S.L.U. |
R |
|
|
|
27.04.2021 |
|
|
|
Jah |
| Müügiloaga pakend |
1706408
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
480mcg 0.5ml 0.5ml 10TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1664849
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
300mcg 0.5ml 0.5ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1735848
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
480mcg 0.5ml 0.5ml 7TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1706396
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
480mcg 0.5ml 0.5ml 3TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1664850
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
300mcg 0.5ml 0.5ml 5TK |
Accord Healthcare S.L.U. |
R |
|
|
|
13.10.2021 |
|
|
|
Jah |
| Müügiloaga pakend |
1735837
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
300mcg 0.5ml 0.5ml 7TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1664861
|
ACCOFIL |
L03AA02 |
filgrastiim |
süste-/infusioonilahus süstlis |
480mcg 0.5ml 0.5ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
21.11.2016 |
|
|
|
Jah |
| Müügiloata ravim |
1848731
|
ACTIKERALL |
L01BC82 |
fluorouratsiil +salitsüülhape |
nahalahus |
5mg +100mg 1g 25ml 1TK |
ALMIRALL HERMAL GmbH |
R |
|
|
müügiloata pakend |
|
|
|
|
|